Skip to main content
. 2021 Sep 27;102(2):605–652. doi: 10.1152/physrev.00005.2021

FIGURE 1.

FIGURE 1.

Overview of all clinical studies included. A: clinical trials grouped by status and mechanisms. B: chart for proportion of clinical trials with antifibrotic therapies based on organ of interest. C: number of clinical trials over time formatted based on the type of investigated drugs. ECM, extracellular matrix; HMG-CoA, 5-hydroxy-3-methylglutaryl-coenzyme A; RAS, renin-angiotensin system.